A detailed history of Norges Bank transactions in Guardant Health, Inc. stock. As of the latest transaction made, Norges Bank holds 1,192,742 shares of GH stock, worth $51.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,192,742
Holding current value
$51.1 Million
% of portfolio
0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$20.2 - $38.11 $24.1 Million - $45.5 Million
1,192,742 New
1,192,742 $36.4 Million
Q2 2024

Aug 14, 2024

BUY
$16.07 - $31.84 $22.2 Million - $44.1 Million
1,383,768 New
1,383,768 $40 Million
Q4 2023

Feb 09, 2024

BUY
$21.58 - $29.5 $20.4 Million - $27.8 Million
943,433 New
943,433 $25.5 Million
Q3 2023

Nov 13, 2024

BUY
$25.8 - $39.97 $17.7 Million - $27.4 Million
684,286 New
684,286 $20.3 Million
Q3 2023

Nov 13, 2023

SELL
$25.8 - $39.97 $20.2 Million - $31.3 Million
-783,843 Closed
0 $0
Q2 2023

Aug 14, 2024

SELL
$20.94 - $38.01 $12.9 Million - $23.5 Million
-617,101 Reduced 44.6%
766,667 $27.4 Million
Q2 2023

Aug 14, 2023

SELL
$20.94 - $38.01 $16.6 Million - $30.1 Million
-792,040 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$22.92 - $33.76 $24 Million - $35.3 Million
1,045,235 New
1,045,235 $24.5 Million
Q4 2022

Feb 14, 2023

BUY
$25.44 - $59.78 $20 Million - $47 Million
787,043 New
787,043 $21.4 Million
Q3 2022

Nov 13, 2023

BUY
$43.66 - $61.0 $34.2 Million - $47.8 Million
783,843 New
783,843 $42.2 Million
Q2 2022

Aug 14, 2023

BUY
$28.82 - $77.35 $22.8 Million - $61.3 Million
792,040 New
792,040 $32 Million
Q1 2022

May 09, 2022

SELL
$48.25 - $100.49 $41.2 Million - $85.8 Million
-853,902 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$88.71 - $120.43 $75.7 Million - $103 Million
853,902 New
853,902 $85.4 Million
Q3 2021

Nov 14, 2022

BUY
$98.77 - $132.17 $77.5 Million - $104 Million
784,320 New
784,320 $98 Million
Q3 2021

Nov 05, 2021

SELL
$98.77 - $132.17 $77.2 Million - $103 Million
-781,139 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$109.77 - $165.68 $85.7 Million - $129 Million
781,139 New
781,139 $97 Million
Q2 2021

Aug 10, 2021

SELL
$109.77 - $165.68 $76.8 Million - $116 Million
-699,198 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$127.04 - $179.1 $88.8 Million - $125 Million
699,198 New
699,198 $107 Million
Q1 2021

May 07, 2021

SELL
$127.04 - $179.1 $85.4 Million - $120 Million
-672,202 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$99.96 - $135.93 $67.2 Million - $91.4 Million
672,202 New
672,202 $86.6 Million
Q4 2020

Feb 10, 2021

SELL
$99.96 - $135.93 $57.8 Million - $78.6 Million
-578,143 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$80.32 - $111.8 $46.4 Million - $64.6 Million
578,143 New
578,143 $64.6 Million
Q3 2020

Nov 10, 2020

SELL
$80.32 - $111.8 $47.2 Million - $65.7 Million
-587,383 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$60.49 - $97.5 $35.5 Million - $57.3 Million
587,383 New
587,383 $47.7 Million
Q2 2020

Aug 07, 2020

SELL
$60.49 - $97.5 $23.1 Million - $37.2 Million
-381,182 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$59.04 - $88.81 $22.5 Million - $33.9 Million
381,182 New
381,182 $26.5 Million
Q1 2020

May 08, 2020

SELL
$59.04 - $88.81 $22.5 Million - $33.9 Million
-381,182 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$59.49 - $82.78 $22.7 Million - $31.6 Million
381,182 New
381,182 $29.8 Million
Q4 2019

Feb 12, 2020

SELL
$59.49 - $82.78 $22.7 Million - $31.6 Million
-381,182 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$62.59 - $110.3 $23.9 Million - $42 Million
381,182 New
381,182 $24.3 Million
Q3 2019

Nov 08, 2019

SELL
$62.59 - $110.3 $20.8 Million - $36.7 Million
-332,821 Closed
0 $0
Q2 2019

Aug 13, 2020

BUY
$63.94 - $91.11 $21.3 Million - $30.3 Million
332,821 New
332,821 $28.7 Million
Q2 2019

Aug 09, 2019

SELL
$63.94 - $91.11 $2.56 Million - $3.64 Million
-40,000 Closed
0 $0
Q4 2018

Mar 04, 2019

BUY
$29.2 - $46.1 $1.17 Million - $1.84 Million
40,000 New
40,000 $1.5 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.38B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.